RESHAPE INTEGRATED DUAL BALLOON SYSTEM

Implant, Intragastric For Morbid Obesity

FDA Premarket Approval P140012

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the reshape integrated dual balloon system. The reshape integrated dual balloon system is indicated for weight reduction when used in conjunction with diet and exercise, in obese patients with a body mass index (bmi) of 30 40 kg/m2 and one or more obesity-related comorbid conditions. It is indicated for use in adult patients who have failed weight reduction with diet and exercise alone.

DeviceRESHAPE INTEGRATED DUAL BALLOON SYSTEM
Classification NameImplant, Intragastric For Morbid Obesity
Generic NameImplant, Intragastric For Morbid Obesity
ApplicantAppollo Endosurgery
Date Received2014-07-01
Decision Date2015-07-28
Notice Date2015-07-29
PMAP140012
SupplementS
Product CodeLTI
Docket Number15M-2740
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address Appollo Endosurgery 1120 S Capital Of Tx Hwy bldg 1, Ste 300 austin, TX 78746
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P140012Original Filing
S013 2018-05-02 Special (immediate Track)
S012 2018-02-26 Normal 180 Day Track No User Fee
S011 2017-09-27 30-day Notice
S010 2017-04-28 Normal 180 Day Track No User Fee
S009 2017-03-22 Special (immediate Track)
S008 2017-01-23 30-day Notice
S007 2016-12-19 30-day Notice
S006 2016-12-07 30-day Notice
S005 2016-09-26 30-day Notice
S004 2015-12-01 30-day Notice
S003 2015-11-18 Real-time Process
S002 2015-09-28 Normal 180 Day Track
S001 2015-08-26 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
B001RSM9001 P140012 000
B001RSM2101 P140012 000
B001RSM1011 P140012 000
B001RSM1101 P140012 002

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.